Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,398,759
-$184,924 QoQ
Shares Held
58,088
+3.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#1,126
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. PFE ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
This page
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
|
3,665 | $1,327,169 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,398,759 | 58,088 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,583,683 | 56,399 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,464,618 | 58,820 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,288,651 | 50,575 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $1,237,985 | 51,072 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,233,069 | 48,661 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $1,212,367 | 45,698 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,426,394 | 49,288 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,323,985 | 47,319 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,332,638 | 48,023 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,308,649 | 45,455 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,642,777 | 49,526 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $1,839,281 | 50,144 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,400,019 | 58,824 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,961,723 | 57,801 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $2,569,718 | 58,723 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $3,049,695 | 58,167 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,129,703 | 60,454 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,344,119 | 56,632 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,443,699 | 56,817 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $1,965,753 | 50,198 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,828,020 | 50,456 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,783,076 | 48,440 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||